###begin article-title 0
A GATA4/WT1 cooperation regulates transcription of genes required for mammalian sex determination and differentiation
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 435 439 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 479 483 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 752 756 752 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 535 550 <span type="species:ncbi:10090">transgenic mice</span>
In mammals, sex determination is genetically controlled. The SRY gene, located on Y chromosome, functions as the dominant genetic switch for testis development. The SRY gene is specifically expressed in a subpopulation of somatic cells (pre-Sertoli cells) of the developing urogenital ridge for a brief period during gonadal differentiation. Despite this tight spatiotemporal expression pattern, the molecular mechanisms that regulate SRY transcription remain poorly understood. Sry expression has been shown to be markedly reduced in transgenic mice harboring a mutant GATA4 protein (a member of the GATA family of transcription factors) disrupted in its ability to interact with its transcriptional partner FOG2, suggesting that GATA4 is involved in SRY gene transcription.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 217 221 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 257 264 257 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh/Mis</italic>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT1 </italic>
###xml 437 441 437 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 826 830 826 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 855 858 855 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY</italic>
###xml 890 894 890 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 58 61 <span type="species:ncbi:9823">pig</span>
###xml 117 122 <span type="species:ncbi:10090">mouse</span>
###xml 127 132 <span type="species:ncbi:9606">human</span>
###xml 155 160 <span type="species:ncbi:10090">mouse</span>
###xml 284 290 <span type="species:ncbi:9606">humans</span>
###xml 415 420 <span type="species:ncbi:10090">mouse</span>
###xml 422 425 <span type="species:ncbi:9823">pig</span>
###xml 431 436 <span type="species:ncbi:9606">human</span>
###xml 884 889 <span type="species:ncbi:10090">mouse</span>
Although our results show that GATA4 directly targets the pig SRY promoter, we did not observe similar action on the mouse and human SRY promoters. In the mouse, Wilms' tumor 1 (WT1) is an important regulator of both Sry and Mullerian inhibiting substance (Amh/Mis) expression and in humans, WT1 mutations are associated with abnormalities of sex differentiation. GATA4 transcriptionally cooperated with WT1 on the mouse, pig, and human SRY promoters. Maximal GATA4/WT1 synergism was dependent on WT1 but not GATA4 binding to their consensus regulatory elements in the SRY promoter and required both the zinc finger and C-terminal regions of the GATA4 protein. Although both isoforms of WT1 synergized with GATA4, synergism was stronger with the +KTS rather than the -KTS isoform. WT1/GATA4 synergism was also observed on the AMH promoter. In contrast to SRY, WT1/GATA4 action on the mouse Amh promoter was specific for the -KTS isoform and required both WT1 and GATA4 binding.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
Our data therefore provide new insights into the molecular mechanisms that contribute to the tissue-specific expression of the SRY and AMH genes in both normal development and certain syndromes of abnormal sex differentiation.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 120 121 120 121 <underline xmlns:xlink="http://www.w3.org/1999/xlink">S</underline>
###xml 136 137 136 137 <underline xmlns:xlink="http://www.w3.org/1999/xlink">R</underline>
###xml 144 145 144 145 <underline xmlns:xlink="http://www.w3.org/1999/xlink">Y</underline>
###xml 492 496 492 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 665 666 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 667 668 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 679 683 679 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 695 696 695 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 737 738 737 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 784 785 784 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 786 787 786 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 921 925 921 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1022 1023 1022 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1041 1045 1041 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1261 1262 1261 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1302 1310 1302 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1325 1326 1325 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1354 1356 1354 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1383 1387 1383 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1537 1539 1537 1539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1574 1578 1574 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1731 1733 1731 1733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1768 1772 1768 1772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1885 1889 1885 1889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 2065 2067 2065 2067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 2068 2070 2068 2070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1034 1039 <span type="species:ncbi:10090">mouse</span>
###xml 1377 1382 <span type="species:ncbi:9606">human</span>
###xml 1561 1566 <span type="species:ncbi:10090">mouse</span>
###xml 1568 1573 <span type="species:ncbi:9606">human</span>
###xml 1816 1819 <span type="species:ncbi:9823">pig</span>
###xml 1821 1826 <span type="species:ncbi:9940">sheep</span>
###xml 1828 1831 <span type="species:ncbi:9615">dog</span>
###xml 1836 1840 <span type="species:ncbi:9925">goat</span>
###xml 2014 2019 <span type="species:ncbi:9606">human</span>
###xml 2052 2057 <span type="species:ncbi:10090">mouse</span>
In eutherian mammals, the gene responsible for triggering testis development, and hence male sex determination, is SRY (Sex Determining Region, Y chromosome) which encodes a putative transcription factor containing a high mobility group box DNA binding domain. SRY initiates the male pathway by triggering the differentiation of Sertoli cells in the genital ridge, the precursor of the developing gonad. During normal mammalian development, the tightly regulated spatiotemporal expression of SRY within the indifferent genital ridges is required for testis determination to proceed. Deregulation of this expression, either via insufficient SRY mRNA concentrations [1,2], delayed SRY expression [3], expression of different SRY isoforms [4], and/or the contribution of autosomal loci [5,6], can result in partial or complete failure of testis determination and the formation of ovotestes or ovaries within XY individuals. SRY expression is now described within the genital ridges of several eutherian mammals (reviewed in [7]). In the mouse, Sry mRNA is first detected by RT-PCR within the somatic cells of the indifferent genital ridges of male embryos at e10.5, with a peak of expression seen at e11.5 followed by a dramatic extinction of expression by e12.5 [8]. These results have been confirmed by in situ hybridization [9] and at the protein level [10]. Expression of the human SRY transcript is first seen within the indifferent male genital ridge beginning at 41 to 44 days post ovulation, corresponding to Carnagie stages 17-18 [11]. In contrast to the mouse, human SRY expression is maintained at low levels within the developing testes for the remainder of gestation, a finding supported by immunohistochemistry results [11]. The genital ridge expression of SRY has now been additionally described for the pig, sheep, dog and goat, and collectively reveals the initiation of SRY transcription within the indifferent male genital ridge followed by a gradual trailing off of expression more similar to the human model of expression than to the mouse model [12-16].
###end p 9
###begin p 10
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 581 585 581 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 702 706 702 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 330 335 <span type="species:ncbi:9606">human</span>
###xml 339 342 <span type="species:ncbi:9823">pig</span>
###xml 577 580 <span type="species:ncbi:9823">pig</span>
###xml 1373 1379 <span type="species:ncbi:9606">humans</span>
Although the essential functional role of SRY has been established for some time [17], surprisingly very little is known about the molecular mechanisms that regulate its spatiotemporal expression. The ability of Wilms' tumor 1 (WT1) and the nuclear receptor steroidogenic factor 1 (NR5A1/SF-1/Ad4BP) to bind and transactivate the human or pig SRY promoters has been demonstrated [18-21], suggesting that these factors contribute to the tissue-specific expression profile of SRY. Moreover, more recent data have shown that the SRY-related factor SOX9 can also transactivate the pig SRY promoter via a consensus SOX9 binding site about 205 bp upstream of the ATG translational start site [22]. After the SRY gene is turned on, testis differentiation ensues; Sertoli cells organize into cord structures that encircle immature germ cells termed gonocytes. At the same time, Leydig cells present in the interstitium of the testicular cords differentiate and begin to secrete testosterone. The next stage of male development is sex differentiation, which takes the form of Mullerian duct (female reproductive tract) regression and Wolffian duct (male reproductive tract) development. These events rely on two hormones produced by the fetal testis: testosterone, secreted by Leydig cells, and Mullerian inhibiting substance (AMH/MIS), produced by Sertoli cells. Absence of AMH in humans causes persistent Mullerian duct syndrome, a form of pseudohermaphroditism characterized by the retention of Mullerian duct structures.
###end p 10
###begin p 11
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 500 504 500 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 694 698 694 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 731 734 731 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY</italic>
###xml 843 847 843 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
###xml 108 111 <span type="species:ncbi:9823">pig</span>
###xml 124 129 <span type="species:ncbi:9940">sheep</span>
###xml 139 142 <span type="species:ncbi:9615">dog</span>
The genital ridge expression of AMH is described in the human (reviewed in [23]), as well as the mouse [8], pig [14,24,25], sheep [12] and dog [26]. AMH expression is restricted to the pre-Sertoli cells of the male genital ridge, always after the initiation of SRY expression and commitant to the time of histological testis cord formation. Once AMH expression is initiated it continues to be expressed at high levels for the duration of the gestational period. The transcriptional regulation of the AMH gene has been studied in detail. Interestingly, several transcription factors involved in primary sex determination (SF-1, WT1, SOX9 and GATA4) are also recruited as important regulators of AMH transcription [27-31]. Much like SRY, however, our understanding of how these factors work together to direct the sex-specific expression of the AMH gene remains incomplete.
###end p 11
###begin p 12
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1001 1003 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1004 1006 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1007 1009 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1024 1028 1024 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT1 </italic>
###xml 1184 1188 1184 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT1 </italic>
###xml 1379 1381 1379 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1658 1660 1658 1660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1661 1663 1661 1663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1741 1744 1741 1744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Wt1</italic>
###xml 1798 1800 1798 1800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1801 1803 1801 1803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1916 1920 1916 1920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1932 1934 1932 1934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1963 1967 1963 1967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1971 1975 1971 1975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 2086 2088 2086 2088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 2089 2091 2089 2091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 2092 2094 2092 2094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 2222 2226 2222 2226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 2230 2234 2230 2234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 2284 2285 2284 2285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 2286 2288 2286 2288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 2488 2490 2488 2490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1016 1022 <span type="species:ncbi:9606">humans</span>
###xml 1750 1754 <span type="species:ncbi:10090">mice</span>
###xml 1816 1820 <span type="species:ncbi:10090">mice</span>
###xml 2183 2188 <span type="species:ncbi:10090">mouse</span>
A common regulatory factor important for transcription of the SRY and AMH genes is WT1. WT1 is a zinc finger transcription factor having both DNA and RNA binding properties [32,33]. There are at least 24 different WT1 isoforms due to alternative transcription start sites, RNA editing, and 2 alternative splicing sites. The first alternative splicing site inserts or removes exon 5, which encodes a 17 amino acid segment upstream of the zinc fingers. The second alternative splicing site, at the end of exon 9, inserts or removes three amino acids (KTS) between zinc fingers 3 and 4. Previous studies have shown that WT1 isoforms with or without the KTS tripeptide have distinct biological functions, whereas the alternative splicing site exon 5 has a modulatory role on WT1 function. Although WT1 was first identified as a tumor-suppressant gene of Wilms' tumor [34,35], subsequent studies revealed that WT1 is also essential for embryonic development, especially the kidney and gonads (reviewed in [34,36-38]). In humans, WT1 gene mutations are responsible for two urogenital diseases: Denys-Drash syndrome (DDS) and Frasier syndrome. DDS is caused by exonic point mutations in the WT1 gene, and is characterized by mesangial sclerosis with early kidney failure, high risk of Wilms' tumor, and varying degrees of gonadal dysgenesis associated with insufficient AMH production [39]. On the other hand, Frasier syndrome, characterized by focal segmental sclerosis, delayed kidney failure and XY gonadal sex reversal, is associated with heterozygous point mutations in intron 9 that cause a shift in the ratio of WT1 isoforms (+/-KTS) towards the -KTS forms [40,41]. The importance of WT1 during gonad development has also be demonstrated by Wt1-null mice, which lack kidneys, gonads, and adrenals [42,43]. Moreover, mice lacking the WT1(+KTS) splice variant show complete XY sex reversal and a dramatic reduction in Sry expression [44]. Consistent with a role in SRY and AMH transcription, in vitro studies have shown that WT1(-KTS) can bind and activate the respective gene promoters [19,45,46]. However, since WT1 starts to be expressed in the developing gonadal primordium of the mouse (e9.5-e10.5) somewhat before the Sry and Amh genes are actually first turned on (e10.5-e12.5) [8,47], and since WT1 is present in several organs where SRY and AMH are not, other factors must cooperate with WT1. Due to its overlapping expression pattern with WT1 in the developing urogenital system [48], GATA4 is an interesting candidate.
###end p 12
###begin p 13
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 390 394 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 409 410 409 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 516 524 516 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 768 772 768 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 801 806 801 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox9 </italic>
###xml 810 814 810 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 829 831 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 958 962 958 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 966 970 966 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 1107 1111 1107 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1114 1117 1114 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH</italic>
###xml 1312 1313 1312 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1314 1316 1314 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1317 1319 1317 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1495 1499 1495 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1503 1507 1503 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 201 206 <span type="species:ncbi:10090">mouse</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
GATA4 is a member of the GATA family of zinc-finger transcription factors that recognize the consensus nucleotide sequence WGATAR (called the GATA motif) in the promoter region of target genes. In the mouse, GATA4 is strongly expressed in the somatic cell population of the developing gonad prior to and during the time of sex determination [48]. This expression pattern coincides with the SRY and AMH genes [8,49], suggesting that GATA4 plays a predominant role in their expression. This hypothesis is supported by in vivo experiments, where mice carrying a GATA4 mutation that disrupts its ability to interact with its transcriptional partner FOG2, display abnormal testis development [50]. On a molecular level, this is apparently due to a significant reduction in Sry transcription and a block in Sox9 and Amh expression [50,51]. Thus GATA4, much like WT1, appears to play a predominant role in both primary sex determination and sex differentiation via SRY and AMH gene regulation. However, since GATA4 is rather broadly expressed, and more specifically, is found in tissues that do not express either SRY or AMH, it too cannot account by itself for the tight spatiotemporal expression of these genes. Interestingly, the developing gonad is a location where GATA4 and WT1 co-localize with both SRY and AMH [8,47-49]. In this study, we provide the first molecular evidence that a physical and functional cooperation between WT1 and GATA4 contributes to the transcriptional regulation of the SRY and AMH gene promoters.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
Species-specific regulation of SRY promoter activity by GATA4
###end title 15
###begin p 16
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 222 226 222 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 478 482 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 759 763 759 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 896 900 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 970 972 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1095 1099 1095 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1141 1143 1141 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1307 1309 1307 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1482 1486 1482 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1539 1543 1539 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1638 1639 1638 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1717 1721 1717 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1815 1819 1815 1819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1879 1883 1879 1883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
###xml 120 123 <span type="species:ncbi:9823">pig</span>
###xml 129 134 <span type="species:ncbi:9606">human</span>
###xml 755 758 <span type="species:ncbi:9823">pig</span>
###xml 890 895 <span type="species:ncbi:10090">mouse</span>
###xml 1089 1094 <span type="species:ncbi:9606">human</span>
###xml 1713 1716 <span type="species:ncbi:9823">pig</span>
###xml 1799 1804 <span type="species:ncbi:10090">mouse</span>
###xml 1809 1814 <span type="species:ncbi:9606">human</span>
There are multiple consensus GATA regulatory motifs within the first 2 kilobases of 5' flanking sequences of the mouse, pig, and human SRY genes (Fig. 1A). Although numerous GATA binding sites are present in the different SRY promoters, they are not necessarily species conserved which is to be expected as SRY 5' flanking sequences are generally poorly conserved between mammals [52]. As shown in Fig. 1B, we tested the ability of GATA4, at varying doses, to transactivate the SRY promoter from these three species by transient transfection assays in the heterologous HeLa epithelial cell line. HeLa cells do not express GATA4 making it a convenient cell line model for promoter regulation studies involving this factor. Of the three species tested, the pig SRY promoter was the most responsive to GATA4 with an activation of about 3-fold (Fig. 1B, middle panel). This was followed by the mouse Sry promoter which was activated by 2-fold in the presence of GATA4 (Fig. 1B, left panel). This 2-fold activation approached significance but was not significant (P > 0.05). Interestingly, the human SRY promoter was not activated by GATA4 (Fig. 1B, right panel), and this despite the presence of multiple consensus GATA binding motifs and the fact that GATA4 could be strongly overexpressed in HeLa cells (Fig. 1C). Similar results were obtained in other heterologous cell lines such as CV-1 fibroblasts (data not shown). The absence or relatively weak ability of GATA4 to activate the SRY promoter suggested that the factor might not bind to SRY GATA motifs with high affinity. However, EMSA analysis revealed the contrary. As shown in Fig. 2, GATA4 was able to strongly bind to all four GATA motifs of the proximal pig SRY promoter. Similar results were obtained with the GATA binding elements of the mouse and human SRY promoters (data not shown). Thus, the mechanism of GATA4 in SRY gene regulation is unlikely one of direct transcriptional activation by GATA4 alone.
###end p 16
###begin p 17
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 0 78 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Transcriptional properties of GATA4 on the mouse, pig, and human <italic>SRY </italic>promoters</bold>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 425 428 425 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY</italic>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
###xml 50 53 <span type="species:ncbi:9823">pig</span>
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 194 199 <span type="species:ncbi:10090">mouse</span>
###xml 201 206 <span type="species:ncbi:9606">human</span>
###xml 212 215 <span type="species:ncbi:9823">pig</span>
###xml 386 391 <span type="species:ncbi:10090">mouse</span>
###xml 402 405 <span type="species:ncbi:9823">pig</span>
###xml 419 424 <span type="species:ncbi:9606">human</span>
Transcriptional properties of GATA4 on the mouse, pig, and human SRY promoters. A. Multiple consensus (but not species conserved) GATA binding motifs are present in the first 2 kilobases of the mouse, human, and pig SRY promoters; the GATA sites are indicated by the lozenges. B. Ability of GATA4 to transactivate the SRY promoter. HeLa cells were co-transfected with either a -1090 bp mouse, -1400 bp pig, or -1250 bp human SRY-luciferase promoter construct (500 ng) along with increasing amounts of a GATA4 expression vector (25, 50, or 100 ng). All promoter activities are reported as fold activation over control +/- S.E.M. Like letters indicate no statistically significant difference between groups (P > 0.05). C. Western blot analysis of nuclear extracts (10 mug) from HeLa cells overexpressing GATA4.
###end p 17
###begin p 18
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 0 35 0 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>SRY </italic>promoter GATA motifs bind GATA4</bold>
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 203 207 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 358 362 358 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mut </sub>
###xml 199 202 <span type="species:ncbi:9823">pig</span>
SRY promoter GATA motifs bind GATA4. An EMSA was performed with recombinant GATA4 protein and a 32P-labeled oligonucleotide probe corresponding to the first consensus GATA motif (GATA site 1) of the pig SRY promoter. Competition with an oligonucleotide containing a mutated GATA motif (GATA to GGTA) was used to confirm the specificity of GATA4 binding (GATAmut site 1). GATA4 binding to the more distal GATA motifs (GATA sites 2-4) was then assessed by competition experiments using the indicated oligonucleotides.
###end p 18
###begin title 19
Transcriptional cooperation between GATA4 and WT1 on the SRY promoter
###end title 19
###begin p 20
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 399 403 399 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 712 716 712 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 1013 1017 1013 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1101 1103 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 1145 1149 1145 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1294 1298 1294 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1397 1399 1397 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 1555 1559 1555 1559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1615 1617 1615 1617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 1759 1763 1759 1763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1886 1888 1886 1888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 2023 2025 2023 2025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 2283 2285 2283 2285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 226 231 <span type="species:ncbi:10090">mouse</span>
###xml 233 236 <span type="species:ncbi:9823">pig</span>
###xml 242 247 <span type="species:ncbi:9606">human</span>
###xml 377 382 <span type="species:ncbi:10090">mouse</span>
###xml 384 387 <span type="species:ncbi:9823">pig</span>
###xml 393 398 <span type="species:ncbi:9606">human</span>
###xml 520 525 <span type="species:ncbi:9606">human</span>
###xml 1288 1293 <span type="species:ncbi:10090">mouse</span>
###xml 1551 1554 <span type="species:ncbi:9823">pig</span>
###xml 1677 1682 <span type="species:ncbi:10090">mouse</span>
###xml 1734 1739 <span type="species:ncbi:10090">mouse</span>
###xml 1744 1747 <span type="species:ncbi:9823">pig</span>
###xml 1753 1758 <span type="species:ncbi:9606">human</span>
Although SRY 5' flanking sequences are known to be divergent in mammals [21,52], in addition to GATA regulatory motifs, 2 partially conserved WT1 binding sites are present within the first 2 kb of 5' flanking sequences of the mouse, pig, and human SRY genes (Fig. 3A). The sequences of the putative WT1 binding sites are shown in Fig. 3B. The TCC repeat elements common to the mouse, pig, and human SRY sequences have been shown to be recognized by both the -KTS and +KTS isoforms of WT1 [53]. The only exception is the human WT1 binding site 1 (5'-GAGGGGGTG-3') which appears to be preferentially recognized by WT1(-KTS) and not WT1(+KTS) [19]. The WT1 isoforms, much like GATA4, were capable of activating the SRY promoter on their own; the magnitude of the activations, however, was greater than GATA4 being on the order of 10-20 fold (Fig. 3D, open bars). Since the WT1 and GATA binding elements lie in close proximity to one another, we tested whether GATA4 could transcriptionally cooperate with WT1 on the SRY promoter by performing co-transfection experiments in heterologous HeLa cells (Fig. 3D, black bars). The three species-specific SRY promoter constructs used in the co-transfection experiments contained both WT1 binding sites and 4 or more consensus GATA elements. On the mouse Sry promoter, both WT1 isoforms strongly synergized with GATA4 with activations reaching 30-fold (Fig. 3D, left panel). Interestingly, the level of GATA4/WT1 synergism was higher with WT1(+KTS) than with WT1(-KTS). Similar results were also observed on the pig SRY promoter where activations reached nearly 50-fold (Fig. 3D, middle panel), as well as in other cell lines such as TM4 mouse Sertoli cells (data not shown). In contrast to the mouse and pig, the human SRY promoter was strongly activated by WT1(-KTS) alone and synergism with GATA4 only occurred with the WT1(+KTS) isoform (Fig. 3D, right panel). Western blot analysis confirmed the heterologous nature of HeLa cells since they are null for both GATA4 and WT1 (Fig. 3C). It also showed that the GATA4/WT1 synergism was not due to variable expression of either GATA4 or the WT1 isoforms since all proteins (whether expressed individually or in combination) were present at similar levels when overexpressed in HeLa cells (Fig. 3C).
###end p 20
###begin p 21
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GATA4 and WT1 transcriptionally cooperate to activate the <italic>SRY </italic>promoter</bold>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 340 344 340 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 603 606 602 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY</italic>
###xml 216 221 <span type="species:ncbi:10090">mouse</span>
###xml 223 228 <span type="species:ncbi:9606">human</span>
###xml 234 237 <span type="species:ncbi:9823">pig</span>
###xml 318 323 <span type="species:ncbi:10090">mouse</span>
###xml 325 328 <span type="species:ncbi:9823">pig</span>
###xml 334 339 <span type="species:ncbi:9606">human</span>
###xml 564 569 <span type="species:ncbi:10090">mouse</span>
###xml 580 583 <span type="species:ncbi:9823">pig</span>
###xml 597 602 <span type="species:ncbi:9606">human</span>
GATA4 and WT1 transcriptionally cooperate to activate the SRY promoter. A. In addition to multiple GATA motifs, two potential WT1 binding sites (indicated by gray circles) are present in the first 2 kilobases of the mouse, human, and pig SRY promoters. B. Nucleotide sequence of the potential WT1 binding sites in the mouse, pig, and human SRY promoters. C. Western blot analysis of HeLa cells extracts (10 mug) overexpressing GATA4 and/or WT1 (+/- KTS) isoforms. D. WT1 and GATA4 transcriptionally cooperate. HeLa cells were co-transfected with either a -1090 bp mouse, -1400 bp pig, or -1250 bp human SRY-luciferase promoter construct (500 ng) along with an empty vector or expression vectors (500 ng) for WT1(-KTS) or WT1(+KTS) in the absence (-) or presence (+) of GATA4 (50 ng). All promoter activities are reported as fold activation over control +/- S.E.M. Like letters indicate no statistically significant difference between groups (P > 0.05).
###end p 21
###begin title 22
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
The proximal WT1 binding site is essential for GATA4/WT1 synergism on the mouse Sry promoter
###end title 22
###begin p 23
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 498 502 498 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 839 843 839 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1170 1172 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1261 1265 1261 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1342 1344 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1419 1421 1419 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 1482 1486 1482 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1734 1736 1730 1732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1865 1869 1861 1865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
###xml 833 838 <span type="species:ncbi:10090">mouse</span>
###xml 1255 1260 <span type="species:ncbi:10090">mouse</span>
###xml 1859 1864 <span type="species:ncbi:10090">mouse</span>
To assess the binding site requirements for transcriptional synergism between GATA4 and WT1, mouse Sry promoter deletion and mutation constructs were prepared and used in co-transfection assays (Fig. 4A). Interestingly, the -340 bp Sry promoter construct (containing an intact proximal WT1 site and no consensus GATA sites) was synergistically activated by GATA4 and WT1 to the same extent as the full-length (-1090 bp) Sry construct. This suggests that GATA4 binding to its consensus sites on the Sry promoter is dispensable for maximal synergism with WT1. Deletion or mutation of the proximal WT1 site, however, abolished the activation by WT1 alone and markedly decreased the synergism between GATA4 and WT1 (Fig. 4A). Thus, in contrast to GATA4, binding of WT1 to its consensus element is critical for GATA4/WT1 synergism on the mouse Sry promoter. Interestingly, GATA4/WT1 synergism was not completely abrogated with the WT1 mutant constructs. The remaining synergism is likely due to two low affinity (not perfect consensus) GATA binding motifs present within the -340 to -70 bp sequence since a further deletion to -40 bp eliminated all WT1/GATA4 synergism (Fig. 4A). These two GATA motifs, named sites A (GTATCT) and B (GTATCT), are unique to the mouse Sry promoter sequence. Although these sites only weakly bind GATA4 protein (Fig. 4B), they are nonetheless functional as revealed by transfection assay (Fig. 4C). The remaining GATA4/WT1 synergism observed on the -340 bp Sry construct harboring the WT1 site mutation (-340 bp WT1 mut.) was abolished when a truncated wild-type GATA4 protein (aa 201-440) was substituted with two GATA4 mutants (C294A or DeltaT279) that we have previously shown to be unable to bind to DNA [54]. Thus, GATA4 binding to these two low affinity GATA motifs likely contributes to the observed GATA4/WT1 synergism on the mouse Sry promoter. We still cannot rule out the possibility, however, of additional unknown regulatory elements (present between -340 and -70 bp) that might be indirectly activated by GATA4/WT1 overexpression in our heterologous HeLa cell line model.
###end p 23
###begin p 24
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 0 119 0 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The mouse <italic>Sry </italic>promoter requires an intact proximal WT1 binding site for full transcriptional synergism by GATA4 and WT1</bold>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 572 574 572 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 675 680 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Star </italic>
###xml 805 809 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 954 958 954 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1041 1045 1041 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
###xml 255 260 <span type="species:ncbi:10090">mouse</span>
###xml 391 396 <span type="species:ncbi:10090">mouse</span>
###xml 668 674 <span type="species:ncbi:10090">murine</span>
###xml 799 804 <span type="species:ncbi:10090">mouse</span>
###xml 948 953 <span type="species:ncbi:10090">mouse</span>
The mouse Sry promoter requires an intact proximal WT1 binding site for full transcriptional synergism by GATA4 and WT1. A. Deletion and mutation analysis of mouse Sry 5' flanking sequences in HeLa cells. HeLa cells were co-transfected with the different mouse Sry promoters (500 ng) as indicated along with an empty vector (control) or expression vectors for GATA4 and/or WT1(+KTS). B. The mouse Sry promoter contains two low affinity GATA binding elements (named sites A and B) located between -340 and -70 bp. An EMSA was performed with recombinant GATA4 protein and a 32P-labeled oligonucleotide probe corresponding to the consensus GATA element from the proximal murine Star promoter [70]. Competition with unlabeled probe (self) and oligonucleotides corresponding to GATA sites A and B of the mouse Sry promoter was used to assess the affinity of GATA4 binding to these sites. C. The low affinity GATA binding sites (A and B) of the proximal mouse Sry promoter are functional. The remaining GATA4/WT1 synergism observed on the -340 bp Sry construct harboring the WT1 site mutation (-340 bp WT1 mut.) is abolished when two different GATA4 DNA-binding mutants (C294A or DeltaT279) are used. For the wild-type and mutated GATA4 constructs, a truncated GATA4 protein (aa 201-440; see diagram in Fig. 6A) was used. For all transfection experiments, promoter activities are reported as fold activation over control +/- S.E.M. Like letters indicate no statistically significant difference between groups (P > 0.05).
###end p 24
###begin p 25
###xml 34 36 34 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 223 227 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 721 725 721 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 920 924 920 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 941 945 941 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 981 983 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1155 1157 1155 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 1254 1258 1254 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1373 1377 1373 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 217 222 <span type="species:ncbi:10090">mouse</span>
###xml 483 486 <span type="species:ncbi:9823">pig</span>
###xml 1178 1181 <span type="species:ncbi:9823">pig</span>
In a DNA-binding experiment (Fig. 5A), WT1 (+ or - KTS) binding to a known consensus WT1 probe was competed using either unlabeled probe or an oligonucleotide corresponding to the proximal WT1 element (site 1) of the mouse Sry promoter. Thus, these results demonstrate that the proximal WT1 site (site 1) is efficiently bound by both WT1 isoforms. The functional importance of the proximal WT1 binding site was confirmed using homologous (WT1 and GATA4-expressing) PGR 9E11 cells, a pig genital ridge cell line [21]. As shown in Fig. 5B, PGR cells express abundant WT1 and GATA4 proteins. Transfection studies carried out in this cell line clearly showed that the deletion or mutation of the proximal WT1 element reduced Sry promoter activity to the same level as the minimal promoter (approximately 33% of the intact construct; Fig. 5C). Thus, WT1 binding to its proximal site is crucial for full basal activity of the Sry promoter. In our Sry promoter deletion experiments (Fig. 4A), we found that GATA binding to its consensus motifs was dispensable for maximal GATA4/WT1 synergism suggesting that GATA4 cooperates with DNA-bound WT1. As shown in Fig. 5D, a ChIP assay using pig PGR cells confirmed that GATA4 is indeed associated with the endogenous SRY promoter in close proximity to the proximal WT1 binding site (ChIP targeting region 2). In contrast, a more distal SRY promoter fragment lacking the critical WT1 site (ChIP targeting region 1) could not be amplified.
###end p 25
###begin p 26
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The proximal WT1 binding site in mouse <italic>Sry </italic>promoter is functional</bold>
###xml 146 148 146 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 241 245 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 447 451 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 877 881 876 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 961 965 960 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1213 1217 1210 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1334 1338 1331 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1653 1657 1646 1650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1795 1799 1788 1792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
###xml 235 240 <span type="species:ncbi:9606">human</span>
###xml 441 446 <span type="species:ncbi:10090">mouse</span>
###xml 538 541 <span type="species:ncbi:9823">pig</span>
###xml 955 960 <span type="species:ncbi:10090">mouse</span>
###xml 1330 1333 <span type="species:ncbi:9823">pig</span>
###xml 1554 1558 <span type="species:ncbi:9925">goat</span>
The proximal WT1 binding site in mouse Sry promoter is functional. A. A DNA-binding assay was performed with in vitro produced WT1 proteins and a 32P-labeled oligonucleotide probe corresponding to the consensus WT1 binding site of the human AMH promoter. WT1 binding (+ or - KTS isoforms) to the labeled probe was blocked by 10-fold excess of unlabeled probe (self) and unlabeled oligo corresponding to the proximal WT1 site (site 1) of the mouse Sry promoter. B. Western blot analysis of nuclear extracts (10 mug) from PGR 9E11 cells (a pig genital ridge cell line) using antisera against WT1 and GATA4. Nuclear extracts from HeLa cells overexpressing WT1(-KTS) and MA-10 Leydig cells were used as positive controls for WT1 and GATA4 expression, respectively. C. Transfection studies performed in homologous PGR cells confirm the importance of the proximal WT1 site for basal Sry promoter activity. PGR cells were transfected with the deleted or mutated mouse Sry promoter constructs (500 ng) as indicated. Results are shown as % activity relative to the intact -340 bp construct +/- S.E.M. Like letters indicate no statistically significant difference between groups (P > 0.05). D. GATA4 is associated with the SRY promoter in PGR genital ridge cells. PGR cell lysates were prepared and interaction of GATA4 with the endogenous pig SRY promoter was studied by ChIP. An aliquot of chromatin preparation before immunoprecipitation (20% input) was used as positive control. Chromatin was precipitated with a GATA4 antiserum (alphaGATA4) or incubated with goat-IgG (IgG) which served as a negative control. A 320-bp DNA fragment spanning a portion of the SRY promoter containing the proximal WT1 binding site (ChIP targeting region 2) was amplified by PCR as indicated by the arrow. A more distal SRY promoter fragment lacking this WT1 site (ChIP targeting region 1) was not amplified.
###end p 26
###begin title 27
The zinc finger domains and the C-terminal region of GATA4 are required for the transcriptional cooperation and physical interaction with WT1
###end title 27
###begin p 28
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 447 451 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 774 776 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 1235 1237 1235 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 1285 1287 1285 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 1392 1394 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 1521 1523 1521 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 1525 1526 1525 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1797 1799 1797 1799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
The strong transcriptional cooperation between GATA4 and WT1 on the SRY promoter suggests that both factors contact each other through a direct protein-protein interaction. The essential nature of this interaction is all the more evident given that GATA4 binding to its consensus motifs is not required for maximal synergism with WT1 (Fig. 4A). To map the domains of the GATA4 protein that interact with WT1 and are important for synergism on the Sry promoter, a series of truncated GATA4 proteins were constructed as depicted in Fig. 6A. The GATA4 protein contains two independent activation domains that flank its DNA-binding domain. Deletion of the N-terminal region (aa 1-200) had no significant effect on the transcriptional synergism between GATA4 and WT1(+KTS) (Fig. 6A). However, GATA4/WT1 synergism was lost using proteins consisting solely of the N-terminal region (aa 1-133), zinc finger region (aa 201-322) or C-terminal domain (aa 302-440). Thus, the zinc finger and C-terminal domains of the GATA4 protein are both required for its ability to transcriptionally cooperate with WT1. Next, the domain of the GATA4 protein involved in the direct physical interaction with WT1 was mapped using in vitro pull-down assays (Fig. 6B). Consistent with the transcription data (Fig. 6A), the WT1 protein (- or +KTS) could physically interact with the intact (wild-type) GATA4 protein (Fig. 6B, far left panel) but not with mutant GATA4 proteins that removed the zinc fingers or C-terminal portions of the protein (Fig. 6B, 3 rightmost panels). Thus, the zinc finger and C-terminal domains of GATA4 are also essential for the physical interaction with WT1. The ability of GATA4 to interact with WT1 in the absence of DNA-binding was further confirmed by a co-immunoprecipitation experiment (Fig. 6C).
###end p 28
###begin p 29
###xml 0 147 0 147 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The zinc finger domains and C-terminal region of the GATA4 protein are required for the transcriptional cooperation and direct interaction with WT1</bold>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 988 990 986 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 1169 1171 1167 1169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 391 396 <span type="species:ncbi:10090">mouse</span>
The zinc finger domains and C-terminal region of the GATA4 protein are required for the transcriptional cooperation and direct interaction with WT1. A. The domain of the GATA4 protein involved in the transcriptional cooperation with WT1 was identified using the full-length GATA protein and four different GATA4 deletion mutants as indicated. HeLa cells were co-transfected with the -340 bp mouse Sry promoter (500 ng) along with an empty vector or expression vectors for the different GATA4 constructs in the absence (-) or presence (+) of a WT1(+KTS) expression vector (500 ng). All promoter activities are reported as fold activation over control +/- S.E.M. The dotted line indicates the activation induced by WT1(+KTS) alone. *, Significantly different from the activation elicited by WT1 alone (P < 0.05). B. In vitro pull-down assays were performed using 500 ng of bacterially produced HIS-WT1(-KTS), HIS-WT1(+KTS) and HIS-LacZ fusion (-ve control) proteins and in vitro translated 35S-labeled GATA4 proteins. After extensive washes, the bound proteins were separated on a 10% SDS-PAGE gel and visualized by autoradiography. Input corresponds to 10% of the total 35S-GATA4 used in each assay. C. GATA4 interacts with both WT1(-KTS) and WT1(+KTS) isoforms. HeLa cells were transfected with expression vectors for either GATA4 alone or GATA4 in the presence of WT1 (+ or -KTS isoforms). A 100-mug aliquot of nuclear extract was then immunoprecipitated (IP) with an antibody for WT1. The precipitated material was then subjected to Western blot (WB) analysis for GATA4. The nuclear extracts used in the IPs were also directly immunoblotted (2.5 mug per lane) to control for the specificity of the GATA4 and WT1 antisera.
###end p 29
###begin title 30
GATA4/WT1 transcriptional synergism also regulates activity of the AMH promoter
###end title 30
###begin p 31
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 487 491 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 583 587 583 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 774 778 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 851 855 851 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 928 931 928 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mh </italic>
###xml 1126 1130 1126 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 1145 1146 1145 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1170 1174 1170 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 1188 1196 1188 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1197 1199 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 1245 1249 1245 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 1264 1266 1264 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 1306 1310 1306 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 1343 1347 1343 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1528 1532 1528 1532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 1651 1655 1651 1655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 1711 1713 1711 1713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 1718 1720 1718 1720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 1827 1831 1827 1831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 1861 1863 1861 1863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 1868 1870 1868 1870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D</xref>
###xml 2025 2027 2025 2027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 2167 2169 2167 2169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D</xref>
###xml 2195 2199 2195 2199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 2244 2248 2244 2248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 913 918 <span type="species:ncbi:10090">mouse</span>
Since we found in the present study that GATA4 and WT1 could cooperate to regulate transcription from the SRY promoter, we surmised that the expression of other gonadal genes might also be modulated by this functional cooperation. Another obvious target in the sex determination/sex differentiation pathway is the AMH gene since its proximal promoter region contains species-conserved binding elements for both GATA4 and WT1 [see Additional file 1]. Both factors are known regulators of AMH transcription [45,48], which is mediated through their direct association with the proximal AMH promoter as shown by ChIP (ref. [45] and data not shown). To better define the role of GATA4 as a transcriptional partner for WT1 in the cell-specific and developmental regulation of the AMH gene, we tested whether GATA4 and WT1 could synergistically activate the AMH promoter. In our co-transfection experiments, we used the mouse -180 bp Amh promoter which contains the GATA and WT1 binding sites in their normal context, as well a series of synthetic constructs containing either GATA and/or WT1 elements placed upstream of the minimal Amh promoter (Fig. 7). Although crucial for Amh transcription in vivo [50], GATA4 by itself is a poor activator of the Amh promoter (Fig. 7A). While WT1 alone weakly activated the Amh promoter, and in contrast to the Sry promoter, only the -KTS isoform was transcriptionally active. In the presence of both proteins, however, a strong synergistic activation was observed not only on the native -180 bp Amh promoter but also a synthetic reporter consisting of two consensus GATA motifs placed upstream of the minimal (-65 bp) Amh promoter containing an intact WT1 binding element (Fig. 7A and 7C). Finally, to assess the binding site requirements for GATA4/WT1 synergism, mutations or deletions of the Amh promoter were generated (Fig. 7B and 7D). Although activation by GATA4 alone was retained using a construct with intact GATA motifs but a mutated WT1 element, GATA4/WT1 synergism was lost (Fig. 7B). Similarly, no GATA4/WT1 synergism was observed on a construct containing an intact WT1 binding site but deleted of the GATA motifs (Fig. 7D). Thus, again unlike the SRY promoter, maximal GATA4/WT1 synergism on the AMH promoter requires both GATA4 and WT1 binding.
###end p 31
###begin p 32
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 0 138 0 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Transcriptional synergism between GATA4 and WT1 on the <italic>Amh </italic>promoter requires GATA4 and WT1 binding to their respective regulatory elements</bold>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 456 460 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
Transcriptional synergism between GATA4 and WT1 on the Amh promoter requires GATA4 and WT1 binding to their respective regulatory elements. A. The native -180 bp Amh promoter containing the GATA and WT1 elements in their natural context. B. A synthetic reporter containing two consensus GATA motifs upstream of the minimal Amh promoter with its WT1 binding site mutated. C. A synthetic reporter containing two consensus GATA motifs upstream of the minimal Amh promoter with an intact WT1 binding site. D. The minimal Amh promoter containing only a WT1 binding site. In all experiments, HeLa cells were co-transfected with the different promoter constructs (500 ng) along with an empty vector or expression vectors for the WT1(-KTS) (500 ng) and GATA4 (100 ng) used alone or in combination. All promoter activities are reported as fold activation over control +/- S.E.M. Like letters indicate no statistically significant difference between groups (P > 0.05).
###end p 32
###begin title 33
###xml 82 88 <span type="species:ncbi:9606">humans</span>
A mutated form of WT1 (WT1 R394W) that causes the retention of Mullerian ducts in humans fails to synergize with GATA4
###end title 33
###begin p 34
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 580 584 580 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 990 994 990 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 1093 1094 1093 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1199 1203 1199 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 291 296 <span type="species:ncbi:9606">human</span>
###xml 1302 1310 <span type="species:ncbi:9606">patients</span>
There are several naturally occurring WT1 mutants known to cause male pseudohermaphroditism with retention of Mullerian ducts (reviewed in [55]). One of these mutants, WT1 R394W, was shown to be a poor activator of the AMH promoter [45]. To better explain the molecular mechanism behind the human phenotype associated with the mutation, we were interested in verifying whether the WT1 R394W mutant could still transcriptionally cooperate with GATA4. As shown in Fig. 8, the WT1 R394W mutant, unlike its wild-type counterpart (- or + WT1 isoforms), not only failed to activate the Amh promoter but also failed to synergize with GATA4. This lack of synergism was not related to the stability or expression level of the mutant protein (data not shown). Rather, the lack of synergism is most likely attributable to a decrease in DNA binding affinity of the mutant WT1 protein for its binding element [45]. This result therefore supports our previous observation that GATA4/WT1 synergism on the AMH promoter absolutely requires binding of both factors to their respective regulatory elements (Fig. 7). Thus, a failed transcriptional synergism between GATA4 and the mutant WT1 protein at the level of the AMH promoter could be a contributing factor to the improper male sex differentiation seen in WT1 R394W patients involving insufficient AMH production.
###end p 34
###begin p 35
###xml 0 114 0 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A mutated form of WT1 (WT1 R394W) that causes retention of M&#252;llerian ducts in humans fails to synergize with GATA4</bold>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 78 84 <span type="species:ncbi:9606">humans</span>
###xml 159 164 <span type="species:ncbi:10090">mouse</span>
A mutated form of WT1 (WT1 R394W) that causes retention of Mullerian ducts in humans fails to synergize with GATA4. A. HeLa cells were co-transfected with the mouse -180 bp Amh promoter and either an empty expression vector (control) or expression vectors for GATA4 (100 ng), WT1(-KTS) wild-type (500 ng) or WT1(-KTS) R394W DDS mutant (500 ng), used alone or in combination as indicated. All promoter activities are reported as fold activation over control +/- S.E.M. Like letters indicate no statistically significant difference between groups (P > 0.05).
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 706 710 706 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 756 760 756 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 1123 1127 1123 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1032 1037 <span type="species:ncbi:9606">human</span>
SRY is the genetic trigger for male sex determination in mammals. Although its critical developmental function has been established for more than 15 years now [17], the molecular mechanisms that regulate its tight spatiotemporal expression in the developing genital ridge have remained elusive. Although a number of transcriptional regulators including SF-1, SOX9 and WT1 have been proposed to participate in SRY gene regulation [18-21,46], the sum of these factors still do not explain its highly restricted expression pattern. We report here, a novel transcriptional cooperation between WT1 and the GATA4 transcription factor. This important cooperation not only markedly enhances transcription from the SRY promoter but also targets the promoter of the AMH gene involved in male sex differentiation. Thus, our data provide new insights into the molecular mechanisms that control the tissue- and developmental-specific expression of these two critical genes and identify GATA4 as a potential causative factor in cases of abnormal human sex development such as Frasier syndrome (XY male-to-female sex reversal with intact SRY gene) and DDS syndrome (incomplete sex differentiation associated with reduced AMH levels).
###end p 37
###begin p 38
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 474 478 474 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 543 547 543 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 676 680 676 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 732 733 732 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 842 846 842 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 953 957 953 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1114 1118 1114 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1455 1459 1455 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1483 1487 1483 1487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1585 1587 1585 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1618 1622 1618 1622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1677 1681 1677 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1691 1693 1691 1693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1694 1696 1694 1696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1775 1779 1775 1779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1973 1977 1973 1977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 2042 2046 2042 2046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 2089 2091 2089 2091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 2116 2120 2116 2120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 2335 2339 2335 2339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 2429 2433 2429 2433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fog2</italic>
###xml 2503 2507 2503 2507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 2519 2521 2519 2521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 2644 2646 2644 2646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 2647 2649 2647 2649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 2758 2760 2758 2760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
###xml 219 225 <span type="species:ncbi:9606">humans</span>
###xml 275 280 <span type="species:ncbi:10090">mouse</span>
###xml 562 567 <span type="species:ncbi:10090">mouse</span>
###xml 569 572 <span type="species:ncbi:9823">pig</span>
###xml 577 582 <span type="species:ncbi:9606">human</span>
###xml 647 652 <span type="species:ncbi:10090">mouse</span>
###xml 672 675 <span type="species:ncbi:9823">pig</span>
###xml 1010 1013 <span type="species:ncbi:9823">pig</span>
###xml 1018 1023 <span type="species:ncbi:10090">mouse</span>
###xml 1053 1058 <span type="species:ncbi:9606">human</span>
###xml 1250 1255 <span type="species:ncbi:9606">human</span>
###xml 1371 1386 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1529 1534 <span type="species:ncbi:10090">mouse</span>
###xml 2439 2443 <span type="species:ncbi:10090">mice</span>
In the mouse, GATA4 is strongly expressed in the somatic cell population of the developing gonad prior to and during the time of Sry expression [48]; GATA4 is also detected in Sertoli cells of the early fetal testis in humans [56]. Moreover, more recent knockout data in the mouse revealed that a functional GATA4 protein is required for Sry expression and hence normal testis cord formation [50], suggesting that GATA4 is essential for either the onset or up-regulation of Sry transcription in the developing male genital ridge. Although the SRY promoters from mouse, pig and human all contain multiple consensus GATA regulatory motifs, only the mouse and especially the pig SRY 5' flanking sequences were activated by GATA4 (Fig. 1). This was not surprising knowing that while SRY function is highly conserved across all mammalian species, SRY promoter regulatory sequences are not. Thus, it is entirely conceivable that GATA4 might directly regulate SRY transcription in some mammalian species (such as the pig and mouse) but not others (such as the human). For these other species, GATA4 likely contributes to SRY transcription through interactions with other transcriptional regulators. Due to its implication in many clinical cases of abnormal human sex development, an interesting candidate for this GATA4-interacting factor is WT1. Indeed, a previous study using transgenic mice expressing green fluorescent protein (GFP) under the control of the Sry promoter has shown that Sry is expressed only in somatic cells of the mouse genital ridge that also co-express GATA4 and WT1 [57]. Consistent with its role in SRY gene regulation, WT1 has been reported to activate the SRY promoter [19,46]. Much like GATA4, however, it alone cannot account for the highly restricted SRY expression pattern since WT1 is found in tissues where SRY is not. Given the co-localization of GATA4 and WT1 in the genital ridge, we surmised that both factors might cooperate to regulate the SRY gene. Indeed, GATA4 strongly synergized with WT1 to activate the SRY promoter of all three species tested (Fig. 3D). Thus, we propose that SRY expression is controlled by a GATA4/WT1 transcriptional cooperation rather than by the action of GATA4 or WT1 alone. Although this mechanism helps us to better understand the proper spatiotemporal expression of the SRY gene, other factors must also participate. This includes SOX9, SF-1, and especially FOG2. Fog2-null mice have disrupted testicular development and markedly reduced Sry expression [50]. FOG2 was originally cloned as a cofactor for GATA4 and this interaction is essential for normal testis differentiation [50,51]. Although most in vitro studies point to FOG2 acting as a co-repressor for GATA4 transcriptional activity [58], whether this is actually the case in vivo remains to be shown.
###end p 38
###begin p 39
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDH1 </italic>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 682 686 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MYC </italic>
###xml 687 692 687 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C-MYC</italic>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 755 759 755 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1072 1074 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1152 1154 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 1176 1180 1176 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1240 1242 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 1427 1431 1427 1431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1492 1496 1492 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT1 </italic>
###xml 1624 1626 1624 1626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1627 1629 1627 1629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 676 681 <span type="species:ncbi:9606">human</span>
###xml 749 754 <span type="species:ncbi:10090">mouse</span>
###xml 1170 1175 <span type="species:ncbi:10090">mouse</span>
###xml 1486 1491 <span type="species:ncbi:9606">human</span>
Our results provide strong evidence that both the WT1(-KTS) and WT1(+KTS) isoforms act as transcriptional activators of the SRY promoter. It is generally accepted, however, that WT1(-KTS) functions as a transcriptional regulator whereas WT1(+KTS) plays a role in other cellular processes, such as RNA processing [59]. Indeed, to date, only a few genes have been identified as potential transcriptional targets of WT1(+KTS). For example, transactivation of the CDH1 (cadherin 1/E-cadherin) gene, which encodes a calcium-dependent cell adhesion protein, is enhanced by WT1 (+KTS) through GC-rich and CAAT box sequences [60]. Moreover, WT1(+KTS) can activate the promoter of the human MYC (C-MYC) gene via two WT1 binding sites [61]. We found that the mouse Sry promoter contains two possible WT1 binding sites, a distal site at -940 bp (5'-GGAGGA-3') and a proximal one at -50 bp (5'-GGAGGAGGGA-3') upstream of the transcription start site. Their sequences are antisense to a TCC-repeat element which has been identified as a binding motif for both WT1(-KTS) and WT1(+KTS) [53]. Indeed, our results showed that WT1(+KTS) binds to the proximal site (Fig. 5A) and activates mouse Sry promoter activity alone and in association with GATA4 (Fig. 3D). Thus taken together, although the target genes of WT1(+KTS) are limited in comparison to WT1(-KTS), WT1(+KTS) nonetheless appears to be an important transcriptional regulator of the SRY gene. This is not surprising given that the best known human WT1 mutation associated with sex reversal (Frasier syndrome) produces a shift in the WT1 +/-KTS ratio that favors the -KTS isoform [40,41].
###end p 39
###begin p 40
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 188 192 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 468 472 468 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 657 662 657 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox9 </italic>
###xml 666 669 666 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh</italic>
###xml 685 688 685 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry</italic>
###xml 752 756 752 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 881 885 881 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 988 992 988 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1152 1156 1152 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1318 1322 1318 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT1 </italic>
###xml 1483 1486 1483 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT1</italic>
###xml 1769 1771 1769 1771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1772 1774 1772 1774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1837 1841 1837 1841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 2000 2004 2000 2004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 2079 2081 2079 2081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 2143 2147 2143 2147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 400 405 <span type="species:ncbi:10090">mouse</span>
###xml 571 576 <span type="species:ncbi:10090">mouse</span>
###xml 875 880 <span type="species:ncbi:10090">mouse</span>
###xml 1015 1020 <span type="species:ncbi:10090">mouse</span>
###xml 1251 1256 <span type="species:ncbi:9606">human</span>
###xml 1403 1411 <span type="species:ncbi:9606">patients</span>
###xml 1687 1692 <span type="species:ncbi:9606">human</span>
###xml 1703 1708 <span type="species:ncbi:10090">mouse</span>
###xml 1831 1836 <span type="species:ncbi:9606">human</span>
###xml 1994 1999 <span type="species:ncbi:9606">human</span>
###xml 2137 2142 <span type="species:ncbi:9606">human</span>
Interestingly, the level of GATA4/WT1 synergism on the SRY promoter was much stronger when the WT1(+KTS) isoform was used. Importantly, this observation might improve our understanding of Sry regulation in mutant mice as reported by Hammes et al. [44]. They showed that mutant mice that express only WT1(-KTS) or WT1(+KTS) have distinct functions in sex determination and gonad development [44]. The mouse mutant lacking the WT1(+KTS) isoform exhibited a reduction in Sry expression (less than 25% of wild-type) leading to a block in testis development. In contrast, the mouse mutant lacking WT1(-KTS) still showed modest expression of male specific genes (Sox9 and Amh) downstream of Sry, suggesting that WT1(+KTS), and not WT1(-KTS) is essential for Sry expression and consequently normal testis development. We show here that the level of GATA4/WT1(+KTS) synergism on the mouse Sry promoter was more than twice that of GATA4/WT1(-KTS). Thus, our findings suggest that the reduction in Sry expression seen in the mouse lacking WT1(+KTS) might be the result of a lack of appropriate GATA4/WT1(+KTS) synergism and hence, insufficient activation of the Sry promoter. The importance of WT1 in male sex determination has also been well-documented in the human since several diseases have been shown to be associated with WT1 mutations, such as DDS and Frasier syndrome. Male-to-female sex reversal seen in patients with Frasier syndrome is caused by heterozygous mutations in exon 9 of WT1, which as previously mentioned, results in reduced levels of the WT1(+KTS) isoform and an concomitant increase in WT1(-KTS). Thus, WT1(+KTS) is believed to be critical for testis determination in the human as in the mouse. Contrary to these in vivo data, however, previous reports [19,20], as well as our present in vitro studies show that the human SRY promoter to be comparatively less responsive to WT1(+KTS) than WT1(-KTS). Despite this observation, we found that GATA4 enhances WT1(+KTS) action on the human SRY promoter; an effect that was not observed with the WT1(-KTS) isoform (Fig. 3D), suggesting that WT1(+KTS) also likely contributes to human SRY transcription in cooperation with GATA4.
###end p 40
###begin p 41
###xml 126 130 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 472 476 472 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 683 687 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 792 796 792 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 816 818 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 877 881 877 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 905 909 905 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1074 1076 1074 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1137 1141 1137 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 1156 1157 1156 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1249 1253 1249 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1257 1261 1257 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 1363 1365 1363 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1366 1368 1366 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1369 1371 1369 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1372 1374 1372 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
In the mouse, immediately after sex determination (testis differentiation), male sex differentiation ensues with the onset of Amh expression by the newly differentiated Sertoli cells. To date, four transcription factors, all acting within the first 180 bp of 5' flanking sequences, have been proposed to be involved in the sex-specific regulation of the Amh gene: SF-1, WT1, SOX9, and GATA4 [27-31]. Based on several in vitro and in vivo studies [27-29], up-regulation of Amh gene expression in the fetal testis appears to require the presence of both SF-1 and WT1. Moreover, it has been reported that SOX9 binding to its specific response element is essential for the initiation of Amh transcription [27]. Studies from our group and others have also shown GATA4 to be an important player in AMH gene regulation [54,62,63]. We now show that the WT1-dependent regulation of the Amh promoter, much like the Sry promoter, is markedly enhanced by GATA4. An important difference, however, was the promoter-specific response to the WT1 isoforms. Consistent with previous reports [29], WT1(-KTS) was the transcriptionally active isoform on the Amh promoter (Fig. 7 and data not shown). Thus, WT1(+KTS) and WT1(-KTS) appear to have different actions on the SRY and AMH promoters as has been described for other WT1 target genes involved in the sex determination pathway [19,20,45,64].
###end p 41
###begin title 42
Conclusion
###end title 42
###begin p 43
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MIS </italic>
Taken together, our data not only provide new insights into the molecular mechanisms that contribute to the tissue-specific expression of the SRY and MIS genes but also highlight the importance of GATA4 a key regulator of gonadal development by acting a two levels in the mammalian sex determination and differentiation cascade.
###end p 43
###begin title 44
Methods
###end title 44
###begin title 45
Plasmids
###end title 45
###begin p 46
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 513 516 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 519 522 519 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 612 616 612 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1083 1087 1083 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1211 1215 1207 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1384 1388 1380 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1424 1428 1420 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1857 1860 1853 1856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh</italic>
###xml 1924 1926 1920 1922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1943 1947 1939 1943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amh </italic>
###xml 2547 2549 2543 2545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 2550 2552 2546 2548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 2553 2555 2549 2551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 2556 2558 2552 2554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 11 14 <span type="species:ncbi:9823">pig</span>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 162 167 <span type="species:ncbi:10090">mouse</span>
###xml 260 263 <span type="species:ncbi:9823">pig</span>
###xml 348 353 <span type="species:ncbi:9606">human</span>
###xml 606 611 <span type="species:ncbi:10090">mouse</span>
###xml 1077 1082 <span type="species:ncbi:10090">mouse</span>
###xml 1378 1383 <span type="species:ncbi:10090">mouse</span>
###xml 1418 1423 <span type="species:ncbi:10090">mouse</span>
###xml 1850 1856 <span type="species:ncbi:10090">murine</span>
###xml 2598 2603 <span type="species:ncbi:10090">mouse</span>
The mouse, pig and human SRY promoters were amplified by PCR using the corresponding species-specific genomic DNA as template and the following pairs of primers: mouse (forward: 5'-CGGGATCCGCTGTATTGTCAATAAAACAG-3', reverse: 5'-GGGGTACCGACAATTGTCACCAGTCCC-3'); pig (forward: 5'-CGGGATCCTTTGAGTTCCAAGG-3', reverse: 5'-GGGGTACCGAAAAGGGGGAGGAAGCG-3'); human (forward: 5'-CGGGATCCAATTCATATAGCTTTTTGTGTCC-3', reverse: 5'-GGGGTACCTCAACACCCCCTCAAC-3'). The different promoters fragments were subsequently cloned into the BamHI/KpnI site of a modified luciferase expression vector [65]. Deletion constructs for the mouse Sry promoter were generated by PCR using the following pairs of primers: -820 bp (forward: 5'-CGGGATCCGCCGTAGTAGACTATGATAC-3', reverse: 5'-GGGGTACCGACAATTGTCACCAGTCCC-3'); -340 bp (forward: 5'-CGGGATCCCTTTCCACTACTTTTGCA-3', reverse: 5'-GGGGTACCGACAATTGTCACCAGTCCC-3'); -40 bp (forward: 5'-CGGGATCCTTACACACGTTAAATATTAAAATC-3', reverse: 5'-GGGGTACCGACAATTGTCACCAGTCCC-3'). Promoter fragments were then cloned into the luciferase reporter as described above. The -340 mouse Sry promoter construct with a specific deletion of the WT1 response element (DeltaWT1) was achieved by cloning a -340 to -70 bp Sry promoter fragment, obtained by PCR (forward primer: 5'-CGGGATCCCTTTCCACTACTTTTGCA-3', reverse primer: 5'-GAAGATCTCTAGTCCAGCCCAACTAATC-3'), in front of the minimal mouse Sry promoter construct. A -340 bp mouse Sry promoter construct harboring a mutation that inactivates the WT1 element (GGAGGAGGGA to GGTGTTGGGT) was generated using the QuikChange XL mutagenesis kit (Stratagene, La Jolla, CA) according to the manufacture's recommendations along with the following oligonucleotides - sense: 5'-GACTAGGGAGGTCCTGAAGGTGTTGGGTTAAATATTTTCTTACAC-3'; antisense: 5'-GTGTAAGAAAATATTTAACCCAACACCTTCAGGACCTCCCTAGTC-3'. The natural and synthetic murine Amh-luciferase promoter constructs have been described previously [31]. The synthetic Amh promoter construct containing a WT1 binding site mutation was generated by site-directed mutagenesis using the following primer pair - sense: 5'-TACAGCAAGGCCCGGGCGGCCCCGCTTATATGTA-3'; antisense: 5'-TACATATAAGCGGGGCCGCCCGGGCCTTGCTGTA-3'. Finally, the WT1(-KTS) DDS (R394W) mutant was also made by site-directed mutagenesis using the wild-type WT1 cDNA as template and the following primers - sense: 5'-CTTCAGATGGTCGGACCAGGAAAACTTTCGCTG -3'; antisense: 5'-CAGCGAAAGTTTTCCTGGTCCGACCATCTGAAG-3'. The GATA4 expression vectors (wild-type, deletions and DNA-binding mutants) have been described previously [31,54,62,66]. Expression vectors for the wild-type mouse WT1 isoforms were kindly provided by Dr. Jerry Pelletier (McGill University). All plasmid constructs were verified by sequencing.
###end p 46
###begin title 47
Cell culture and transfections
###end title 47
###begin p 48
###xml 34 36 34 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 345 347 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 498 502 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1121 1122 1113 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 0 3 <span type="species:ncbi:9823">Pig</span>
###xml 87 91 <span type="species:ncbi:9913">calf</span>
###xml 128 133 <span type="species:ncbi:9606">human</span>
###xml 227 233 <span type="species:ncbi:9913">bovine</span>
Pig genital ridge PGR 9E11 cells [21] were grown in DMEM supplemented with 10% newborn calf serum at 37degreesC and 5% CO2. The human cervical carcinoma HeLa cell line was maintained in 1:1 DMEM/Ham's F-12 containing 10% fetal bovine serum. HeLa cells were transfected in 24-well culture plates using the calcium phosphate precipitation method [67]. PGR 9E11 cells were seeded in 12-well plates and transfected using the LipofectAMINE reagent (Invitrogen, Burlington, Canada). In brief, 2.5 mug of SRY promoter-luciferase reporters were transfected with 2.5 mul of LipofectAMINE reagent per well in serum- and antibiotic-free media. A renilla (phRL-TK) luciferase plasmid (Promega, Madison, WI) was used as an internal control. Complete medium was added 5 h after transfection. The next day, the cells were harvested and analyzed using the Dual-Luciferase reporter assay system from Promega. The data reported represent the averages of at least three experiments, each done in duplicate. For the experiments presented herein, the internal control was unaffected by either GATA4 or WT1 overexpression [see Additional file 2].
###end p 48
###begin title 49
Nuclear extracts and Western blots
###end title 49
###begin p 50
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
Nuclear extracts were prepared by the procedure outlined by Schreiber et al. [68]. In Western analyses, 10-mug aliquots of nuclear extracts from untreated PGR 9E11 or transfected HeLa cells with GATA4 and/or WT1 expression vectors were separated by SDS-PAGE and then electrotransferred to Hybond PVDF membranes (GE Healthcare Life Sciences, Baie d'Urfe, Canada). Immunodetection of the GATA4 protein was achieved using a GATA4 antiserum (catalog # sc-1237; Santa Cruz Biotechnology, Santa Cruz, CA). WT1 proteins were detected using an anti-WT1 antibody (catalog # sc-192; Santa Cruz) and a VECTASTAIN-ABC-Amp Western blot detection kit (Vector Laboratories Canada, Burlington, Canada). Duolux (Vector) was used as chemiluminescent substrate.
###end p 50
###begin title 51
DNA binding (EMSA) assays
###end title 51
###begin p 52
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 204 206 204 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 564 568 564 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mut </sub>
###xml 816 820 816 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1276 1280 1276 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 1370 1375 1370 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Star </italic>
###xml 1865 1869 1865 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 2020 2022 2020 2022 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 2117 2121 2117 2121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMH </italic>
###xml 2322 2324 2322 2324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2439 2443 2439 2443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 2584 2588 2584 2588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sry </italic>
###xml 2703 2705 2703 2705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 62 65 <span type="species:ncbi:9823">pig</span>
###xml 309 312 <span type="species:ncbi:9823">pig</span>
###xml 812 815 <span type="species:ncbi:9823">pig</span>
###xml 1270 1275 <span type="species:ncbi:10090">mouse</span>
###xml 1363 1369 <span type="species:ncbi:10090">murine</span>
###xml 1859 1864 <span type="species:ncbi:10090">mouse</span>
###xml 2111 2116 <span type="species:ncbi:9606">human</span>
###xml 2433 2438 <span type="species:ncbi:10090">mouse</span>
To assess binding of GATA4 to the consensus GATA sites in the pig SRY promoter, in vitro translated GATA4 protein was prepared using the TNT system from Promega. DNA binding assays were performed using a 32P-labeled double-stranded oligonucleotide corresponding to the proximal GATA site (GATA site 1) of the pig SRY promoter - sense oligo: 5'-GATCCGCCTTATTATCATAATAAA-3'; antisense oligo: 5'-GATCTTTATTATGATAATAAGGCG-3'. Competition with an oligonucleotide containing a mutated GATA motif (GATA to GGTA) was used to confirm the specificity of GATA4 binding - GATAmut site 1 (sense: 5'-GATCCGCCTTATTACCATAATAAA-3', antisense: 5'-GATCTTTATTATGGTAATAAGGCG-3'). Competition experiments using a series of double-stranded oligonucleotides were then used to confirm GATA4 binding to the more distal GATA motifs in the pig SRY promoter - GATA site 2 (sense: 5'-GATCCATTGGGTTATCTTGAATCA-3', antisense: 5'-GATCTGATTCATGATAACCCAATG-3'); GATA site 3 (sense: 5'-GATCCACATACTGATAATCATCAA-3', antisense: 5'-GATCTTGATGATTATCAGTATGTG-3'); GATA site 4 (sense: 5'-GATCCCCAAGGTTATCTGTTTTTA-3', antisense: 5'-GATCTAAAAACAGATAACCTTGGG-3'). Recombinant GATA4 protein was also used to assess the affinity of GATA4 binding to two non-consensus GATA motifs (named sites A and B) in the proximal mouse Sry promoter. For this specific experiment, the consensus GATA element of the proximal murine Star promoter (sense: 5'-GATCCACTTTTTTATCTCAAGTGA-3'; antisense: 5'-GATCTCACTTGAGATAAAAAAGTG-3') was used as labeled probe. Competition using oligos corresponding to sites A (sense: 5'-GTTCTTTGTATCTTAATACT-3'; antisense: 5'-AGTATTAAGATACAAAGAAC-3') and B (sense: 5'-CTTGACAGTATCTAGGTTCA-3'; antisense: 5'-TGAACCTAGATACTGTCAAG-3') was used to assess the affinity of GATA4 binding to these two sites. A similar approach was used to demonstrate WT1 binding to the proximal WT1 element in the mouse Sry promoter. In vitro translated WT1(-KTS) and WT1(+KTS) proteins were prepared using the TNT system (Promega). WT1 binding assays were performed using a 32P-labeled double-stranded oligonucleotide corresponding to the distal WT1 element of the human AMH promoter (sense oligo: 5'-GGATCACTGGGGAGGGAGATAGGA-3', antisense oligo: 5'-GATCTCCTATCTCCCTCCCCAGTG-3') which has been described as a consensus binding site for both the -KTS and +KTS isoforms of WT1 [20]. Competition experiments using a double-stranded oligonucleotide corresponding to the proximal WT1 site in mouse Sry promoter (sense oligo: 5'-GGATCCTGAAGGAGGAGGGATAA-3', antisense oligo: 5'-GATCTTATCCCTCCTCCTTCAGG-3') was used to confirm WT1 binding to the Sry promoter. For all EMSA experiments, binding reactions and electrophoresis conditions were as described previously [48].
###end p 52
###begin title 53
Production of HIS fusion proteins
###end title 53
###begin p 54
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
###xml 272 300 <span type="species:ncbi:511693">Escherichia coli strain BL21</span>
Recombinant histidine-tagged WT1 fusion proteins (HIS-WT1) were obtained by cloning the coding region of the mouse WT1 protein in-frame with HIS using the commercially available pRSETB fusion protein vector from Invitrogen. The resulting construct was introduced into the Escherichia coli strain BL21, and the fusion protein was produced by inducing the bacterial culture with IPTG. After induction, the bacterial culture was lysed by sonication and the fusion protein was purified using a TALON metal affinity resin (BD Biosciences, Mississauga, Canada) according to instructions outlined by the manufacturer.
###end p 54
###begin title 55
In vitro pull-down assays
###end title 55
###begin p 56
###xml 72 74 72 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 249 251 249 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
In vitro pull-down (protein-protein interaction) assays were done using 35S-labeled in vitro translated GATA4 proteins (wild-type and deletion mutants) and the purified HIS-WT1 and HIS-LacZ fusion proteins coupled to TALON metal affinity resin. The 35S-labeled GATA4 proteins were obtained using the TNT system as described above; the amino acid positions of the different GATA4 proteins used are given in Fig. 6A. Proteins were incubated in 500 mul binding buffer (20 mM Hepes pH 7.9, 70 mM KCl, 20% Glycerol, 0.5% Triton X-100) supplemented with 0.01% BSA for 30 min at room temperature. Bound immunocomplexes were washed three times in washing buffer (60 mM NaH2PO4, 600 mM NaCl, 20% Glycerol, 0.75% Triton X-100), resuspended in Laemmli buffer, and subjected to SDS-PAGE. Proteins were finally electrotransferred to Hybond PVDF membrane and visualized by autoradiography.
###end p 56
###begin title 57
Co-immunoprecipitation
###end title 57
###begin p 58
###xml 266 268 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
Nuclear extracts were prepared from HeLa cells transfected with expression vectors for GATA4 or a combination of GATA4 and WT1. A 100-mug aliquot of each extract was then immunoprecipitated overnight using the WT1 antibody in binding buffer as described previously [69]. Immunocomplexes were then collected by incubation with 20 mul of protein G-Sepharose beads (GE Healthcare Life Sciences) at 4degreesC for 1 h. Bound immunocomplexes were washed four times with binding buffer, resuspended in 30 mul of 1x Laemmli buffer, and subjected to SDS-PAGE. Proteins were electrotransferred to PVDF membrane and subjected to immunoblotting using a 1:1000 dilution of the GATA4 antibody and detected with the Vectastain-ABC-Amp Western blot detection kit.
###end p 58
###begin title 59
Chromatin immunoprecipitation (ChIP) assay
###end title 59
###begin p 60
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1666 1667 1626 1627 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 2160 2164 2106 2110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 2306 2310 2252 2256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY </italic>
###xml 1014 1018 <span type="species:ncbi:9925">goat</span>
###xml 2156 2159 <span type="species:ncbi:9823">pig</span>
###xml 2302 2305 <span type="species:ncbi:9823">pig</span>
PGR cells (4 x 107) were cross-linked with 1% formaldehyde (final concentration) for 10 min at 37degreesC. The cells were then washed 3 times with PBS, resuspended in ChIP lysis buffer [1% SDS, 10 mM EDTA, and 50 mM Tris-HCl (pH 8.0)], and incubated for 10 min at 4degreesC. The lysed cells were sonicated on ice using a BRANSON 450 Sonicator for 5 cycles of 30-sec pulses at 3.5 output control and 80% duty cycle in order to obtain DNA fragments between 200 bp and 1000 bp in size. After centrifugation of the solution for 10 min at 4degreesC, the supernatant was precleared for 2 h at 4degreesC with 20 mul of a protein G-Sepharose bead slurry (GE Healthcare Life Sciences) that had been prepared by washing it 3 times with RIPA buffer [50 mM Tris-HCl (pH 8.0), 5 mM EDTA, 150 mM NaCl, 0.1% SDS, 0.5% Igepal CA-630 (Sigma-Aldrich Canada, Oakville Canada)]. After centrifugation for 10 min at 4degreesC, 500 mul of supernatant was subjected to overnight incubation at 4degreesC with 0.4 mug anti-GATA4 or control goat IgG (Santa Cruz) in immunoprecipitation buffer [20 mM Tris-HCl (pH 8.0), 2 mM EDTA, 150 mM NaCl, 1% Triton X-100]. The immunocomplexes were recovered by a 2 h incubation with 20 mul protein G Sepharose beads. The precipitates were washed 5 times with 1 ml RIPA buffer, 5 times with 1 ml high salt RIPA buffer [50 mM Tris-HCl (pH 8.0), 5 mM EDTA, 500 mM NaCl, 0.1% SDS, 0.5% Igepal CA-630], 3 times with LiCl buffer (250 mM LiCl and 0.1% Igepal CA-630), and finally twice with 1 ml of TE buffer [10 mM Tris-HCl (pH 8.0), 1 mM EDTA]. Protein-DNA complexes were eluted from protein G Sepharose beads by addition of elution buffer (1% SDS, 0.1 M NaHCO3) and rotation at room temperature for 15 min. Cross-links were reversed by addition of 200 mM of NaCl and heating at 65degreesC for 4 h. Proteins were degraded using proteinase K treatment (1 h at 55degreesC) and the DNA fragments were purified using a QIAquick gel extraction kit (Qiagen, Mississauga, Canada). PCR amplifications were done using 1 mul of input chromatin sample and 5 mul of GATA4-immunoprecipitated DNA sample with primers specific for either the distal (ChIP region 1) pig SRY promoter (forward primer: 5'-GTATTCACTTATTTCATTTGGTAAGCCA-3'; reverse primer: 5'-CGAGGTGAACATAACACTTC-3') or the proximal (ChIP region 2) pig SRY promoter (forward primer: 5'-TACTGGGGGCGGAGAAATTG-3'; reverse primer: 5'-GGGTCGCTTGACACGATCCT-3'). PCR amplifications were carried out at 94degreesC for 5 min, followed by 40 cycles of 94degreesC for 30 sec, 60degreesC for 30 sec, and 72degreesC for 30 sec, and a final extension of 5 min at 72degreesC. The PCR products were analyzed by electrophoresis on a 2% ethidium bromide-stained agarose gel. ChIP results were confirmed by at least 2 separate experiments.
###end p 60
###begin title 61
Statistical Analysis
###end title 61
###begin p 62
Statistical comparisons between multiple groups were analyzed by one-way analysis of variance (ANOVA) followed by a Student-Newman-Keuls test. Where normality and/or equal variance among groups was not met, data were analyzed by a Kruskal-Wallis ANOVA followed by a Student-Newman-Keuls test to detect significant differences. P < 0.05 was considered significant. All statistical analyses were done with the aid of the SigmaStat 3.5 software package (Systat Software, Inc., Point Richmond, CA).
###end p 62
###begin title 63
List of abbreviations
###end title 63
###begin p 64
###xml 317 323 <span type="species:ncbi:9913">bovine</span>
RT-PCR: reverse transcriptase-polymerase chain reaction; EMSA: electrophorectic mobility shift assay; DMEM: Dulbecco's modified Eagle's medium; IPTG: isopropyl-1-thio-D-galactopyranoside; PVDF: polyvinylidene difluoride; LacZ: beta-galactosidase; DDS: Denys-Drash syndrome; ChIP: chromatin immunoprecipitation.; BSA: bovine serum albumin.
###end p 64
###begin title 65
Authors' contributions
###end title 65
###begin p 66
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 341 344 <span type="species:ncbi:12814?0.7497633322814768|species:ncbi:11886?0.2234143262858946|species:ncbi:12331?0.0041022404544020195">RSV</span>
###xml 423 426 <span type="species:ncbi:12814?0.7497633322814768|species:ncbi:11886?0.2234143262858946|species:ncbi:12331?0.0041022404544020195">RSV</span>
YM carried out the SRY promoter studies as well as the GATA4/WT1 interaction assays. HT carried out the AMH promoter studies, the transfection experiment in Fig. 4C and the ChIP assay in Fig. 5D. FH performed the DNA-binding experiments. YM and HT analyzed and interpreted the data and generated the initial draft of the manuscript. DWS and RSV conceived of the study, and were responsible for its design and coordination. RSV edited the final version of the manuscript which was read and approved by all authors.
###end p 66
###begin title 67
Supplementary Material
###end title 67
###begin title 68
Additional file 1
###end title 68
###begin p 69
Species conservation of the consensus GATA and WT1 binding sites in the proximal AMH promoter.
###end p 69
###begin p 70
Click here for file
###end p 70
###begin title 71
Additional file 2
###end title 71
###begin p 72
Expression of the renilla luciferase (phRL-TK) control plasmid is not significantly affected by GATA4 and/or WT1 overexpression in HeLa cells.
###end p 72
###begin p 73
Click here for file
###end p 73
###begin title 74
Acknowledgements
###end title 74
###begin p 75
###xml 208 211 <span type="species:ncbi:12814?0.7497633322814768|species:ncbi:11886?0.2234143262858946|species:ncbi:12331?0.0041022404544020195">RSV</span>
###xml 213 216 <span type="species:ncbi:12814?0.7497633322814768|species:ncbi:11886?0.2234143262858946|species:ncbi:12331?0.0041022404544020195">RSV</span>
We thank Dr. Jerry Pelletier (McGill University) for generously providing the WT1 expression plasmids used in this study. This work was supported by a grant from the Canadian Institutes of Health Research to RSV. RSV is titleholder of the Canada Research Chair in Reproduction and Sex Development.
###end p 75
###begin article-title 76
###xml 23 46 <span type="species:ncbi:10092">Mus musculus domesticus</span>
Sex reversal caused by Mus musculus domesticus Y chromosomes linked to variant expression of the testis-determining gene Sry
###end article-title 76
###begin article-title 77
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 80 94 <span type="species:ncbi:10092">Mus domesticus</span>
C57BL/6J-T-associated sex reversal in mice is caused by reduced expression of a Mus domesticus Sry allele
###end article-title 77
###begin article-title 78
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Delayed Sry and Sox9 expression in developing mouse gonads underlies B6-Y(DOM) sex reversal
###end article-title 78
###begin article-title 79
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Sry expression level and protein isoform differences play a role in abnormal testis development in C57BL/6J mice carrying certain Sry alleles
###end article-title 79
###begin article-title 80
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Sex-determining genes on mouse autosomes identified by linkage analysis of C57BL/6J-YPOS sex reversal
###end article-title 80
###begin article-title 81
###xml 79 83 <span type="species:ncbi:10090">mice</span>
A single genetic determinant that prevents sex reversal in C57BL-YPOS congenic mice
###end article-title 81
###begin article-title 82
New insights into the regulation of mammalian sex determination and male sex differentiation
###end article-title 82
###begin article-title 83
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
Expression of Sry, the mouse sex determining gene
###end article-title 83
###begin article-title 84
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
Spatially dynamic expression of Sry in mouse genital ridges
###end article-title 84
###begin article-title 85
Sertoli cell differentiation is induced both cell-autonomously and through prostaglandin signaling during mammalian sex determination
###end article-title 85
###begin article-title 86
###xml 47 52 <span type="species:ncbi:9606">human</span>
SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development
###end article-title 86
###begin article-title 87
Characterization of ovine SRY transcript and developmental expression of genes involved in sexual differentiation
###end article-title 87
###begin article-title 88
Porcine SRY gene locus and genital ridge expression
###end article-title 88
###begin article-title 89
###xml 105 109 <span type="species:ncbi:9823">pigs</span>
Reverse transcription-polymerase chain reaction analysis of genes involved in gonadal differentiation in pigs
###end article-title 89
###begin article-title 90
Sry and Sox9 expression during canine gonadal sex determination assayed by quantitative reverse transcription-polymerase chain reaction
###end article-title 90
###begin article-title 91
###xml 0 4 <span type="species:ncbi:9925">Goat</span>
###xml 42 57 <span type="species:ncbi:10090">transgenic mice</span>
Goat SRY induces testis development in XX transgenic mice
###end article-title 91
###begin article-title 92
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Male development of chromosomally female mice transgenic for Sry
###end article-title 92
###begin article-title 93
###xml 92 97 <span type="species:ncbi:9606">human</span>
Steroidogenic factor-1 contributes to the cyclic-adenosine monophosphate down-regulation of human SRY gene expression
###end article-title 93
###begin article-title 94
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human sex-determining gene SRY is a direct target of WT1
###end article-title 94
###begin article-title 95
The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Mullerian-inhibiting substance, and the androgen receptor
###end article-title 95
###begin article-title 96
Porcine SRY Promoter Is a Target for Steroidogenic Factor 1
###end article-title 96
###begin article-title 97
The porcine SRY promoter is transactivated within a male genital ridge environment
###end article-title 97
###begin article-title 98
AMH/MIS: what we know already about the gene, the protein and its regulation
###end article-title 98
###begin article-title 99
Endocrine and molecular influences on testicular development in Meishan and White Composite boars
###end article-title 99
###begin article-title 100
###xml 173 178 <span type="species:ncbi:9823">swine</span>
Expression levels of Mullerian-inhibiting substance, GATA4 and 17alpha-hydroxylase/17,20-lyase cytochrome P450 during embryonic gonadal development in two diverse breeds of swine
###end article-title 100
###begin article-title 101
Sf1 and Mis expression: molecular milestones in the canine sex determination pathway
###end article-title 101
###begin article-title 102
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development
###end article-title 102
###begin article-title 103
The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian inhibiting substance, in vivo
###end article-title 103
###begin article-title 104
Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression
###end article-title 104
###begin article-title 105
Nuclear receptor steroidogenic factor 1 regulates the Mullerian inhibiting substance gene: a link to the sex determination cascade
###end article-title 105
###begin article-title 106
Transcription factor GATA-4 enhances Mullerian inhibiting substance gene transcription through a direct interaction with the nuclear receptor SF-1
###end article-title 106
###begin article-title 107
Multifunctional proteins suggest connections between transcriptional and post-transcriptional processes
###end article-title 107
###begin article-title 108
Multifunctional zinc finger proteins in development and disease
###end article-title 108
###begin article-title 109
###xml 72 77 <span type="species:ncbi:9606">human</span>
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
###end article-title 109
###begin article-title 110
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
###end article-title 110
###begin article-title 111
WT1--more than a transcription factor?
###end article-title 111
###begin article-title 112
Life, sex, and WT1 isoforms--three amino acids can make all the difference
###end article-title 112
###begin article-title 113
The complex life of WT1
###end article-title 113
###begin article-title 114
Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome
###end article-title 114
###begin article-title 115
Donor splice-site mutations in WT1 are responsible for Frasier syndrome
###end article-title 115
###begin article-title 116
Sugar and spice and all things splice?
###end article-title 116
###begin article-title 117
WT-1 is required for early kidney development
###end article-title 117
###begin article-title 118
YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis
###end article-title 118
###begin article-title 119
Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation
###end article-title 119
###begin article-title 120
Role of Wilms' Tumor 1 (WT1) in the Transcriptional Regulation of the Mullerian-Inhibiting Substance Promoter
###end article-title 120
###begin article-title 121
Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product, WT1
###end article-title 121
###begin article-title 122
###xml 47 53 <span type="species:ncbi:10090">murine</span>
Expression of the Wilms' tumor gene WT1 in the murine urogenital system
###end article-title 122
###begin article-title 123
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
Transcription factor GATA-4 is expressed in a sexually dimorphic pattern during mouse gonadal development and is a potent activator of the Mullerian inhibiting substance promoter
###end article-title 123
###begin article-title 124
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Expression of the mouse anti-mullerian hormone gene suggests a role in both male and female sexual differentiation
###end article-title 124
###begin article-title 125
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Gonadal differentiation, sex determination and normal Sry expression in mice require direct interaction between transcription partners GATA4 and FOG2
###end article-title 125
###begin article-title 126
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
The regulation of Sox9 gene expression by the GATA4/FOG2 transcriptional complex in dominant XX sex reversal mouse models
###end article-title 126
###begin article-title 127
Identification of conserved potentially regulatory sequences of the SRY gene from 10 different species of mammals
###end article-title 127
###begin article-title 128
A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1
###end article-title 128
###begin article-title 129
Modulation of endogenous GATA-4 activity reveals its dual contribution to Mullerian inhibiting substance gene transcription in Sertoli cells
###end article-title 129
###begin article-title 130
A clinical overview of WT1 gene mutations
###end article-title 130
###begin article-title 131
###xml 49 54 <span type="species:ncbi:9606">human</span>
Expression of transcription factor GATA-4 during human testicular development and disease
###end article-title 131
###begin article-title 132
Evidence that Sry is expressed in pre-Sertoli cells and Sertoli and granulosa cells have a common precursor
###end article-title 132
###begin article-title 133
FOG-1 and FOG-2 differentially repress the GATA-dependent activity of multiple gonadal promoters
###end article-title 133
###begin article-title 134
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Insights into the physiological role of WT1 from studies of genetically modified mice
###end article-title 134
###begin article-title 135
E-cadherin is a WT1 target gene
###end article-title 135
###begin article-title 136
Transcriptional activation of c-myc proto-oncogene by WT1 protein
###end article-title 136
###begin article-title 137
GATA factors differentially activate multiple gonadal promoters through conserved GATA regulatory elements
###end article-title 137
###begin article-title 138
###xml 75 78 <span type="species:ncbi:10116">rat</span>
Endogenous expression of Mullerian inhibiting substance in early postnatal rat sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites
###end article-title 138
###begin article-title 139
The Wilms' tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation
###end article-title 139
###begin article-title 140
Transcription factor GATA-4 is activated by phosphorylation of serine 261 via the cAMP/PKA pathway in gonadal cells
###end article-title 140
###begin article-title 141
Nuclear receptor Dax1 represses the transcriptional cooperation between GATA-4 and SF-1 in Sertoli cells
###end article-title 141
###begin article-title 142
High efficiency transformation of mammalian cells by plasmid DNA
###end article-title 142
###begin article-title 143
Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells
###end article-title 143
###begin article-title 144
###xml 138 143 <span type="species:ncbi:9606">human</span>
GATA factors and the nuclear receptors, steroidogenic factor 1/liver receptor homolog 1, are key mutual partners in the regulation of the human 3b-hydroxysteroid dehydrogenase type 2 promoter
###end article-title 144
###begin article-title 145
###xml 149 155 <span type="species:ncbi:10090">murine</span>
Steroidogenic factor-1 influences protein-deoxyribonucleic acid interactions within the cyclic adenosine 3,5-monophosphate-responsive regions of the murine steroidogenic acute regulatory protein gene
###end article-title 145

